These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37875045)

  • 1. Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV.
    Xu Z; Zhou H; Zhang Y; Cheng Z; Wan M; Qin W; Li P; Feng J; Shao S; Xue W; Guo H; Liu B
    Biomed Pharmacother; 2023 Dec; 168():115752. PubMed ID: 37875045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases.
    Tan YQ; Chen HW; Li J
    Drug Des Devel Ther; 2020; 14():3731-3746. PubMed ID: 32982178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research review on the pharmacological effects of astragaloside IV.
    Li L; Hou X; Xu R; Liu C; Tu M
    Fundam Clin Pharmacol; 2017 Feb; 31(1):17-36. PubMed ID: 27567103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside IV: A promising natural neuroprotective agent for neurological disorders.
    Yao M; Zhang L; Wang L
    Biomed Pharmacother; 2023 Mar; 159():114229. PubMed ID: 36652731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An updated role of astragaloside IV in heart failure.
    Zang Y; Wan J; Zhang Z; Huang S; Liu X; Zhang W
    Biomed Pharmacother; 2020 Jun; 126():110012. PubMed ID: 32213428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress.
    Ji C; Luo Y; Zou C; Huang L; Tian R; Lu Z
    BMC Pharmacol Toxicol; 2018 Sep; 19(1):53. PubMed ID: 30176914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV, a saponin from Astragalus membranaceus var. mongholicus, induces expressions of heme recycle proteins via signaling of Nrf2/ARE in cultured macrophages.
    Gong G; Yu H; Zheng Y; Qi B; He H; Yin T; Dong TT; Tsim KW
    J Ethnopharmacol; 2021 Jan; 265():113389. PubMed ID: 32920134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragaloside IV ameliorates cisplatin-induced liver injury by modulating ferroptosis-dependent pathways.
    Guo J; Le Y; Yuan A; Liu J; Chen H; Qiu J; Wang C; Dou X; Yuan X; Lu D
    J Ethnopharmacol; 2024 Jun; 328():118080. PubMed ID: 38521426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research advances on astragaloside-IV in treatment of diabetes mellitus and its complications pharmacological effects].
    You LZ; Lin YX; Fang ZH; Shen GM; Zhao JD; Wang TT
    Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(24):4700-4706. PubMed ID: 29493134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research progress of astragaloside IV in the treatment of atopic diseases.
    Yu S; Peng W; Qiu F; Zhang G
    Biomed Pharmacother; 2022 Dec; 156():113989. PubMed ID: 36411656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of Astragaloside IV: a literature review.
    Ren S; Zhang H; Mu Y; Sun M; Liu P
    J Tradit Chin Med; 2013 Jun; 33(3):413-6. PubMed ID: 24024343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease.
    Gao Y; Su X; Xue T; Zhang N
    Biomed Pharmacother; 2023 Jul; 163():114598. PubMed ID: 37150034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research progress of natural medicine Astragalus mongholicus Bunge in treatment of myocardial fibrosis.
    Ren C; Zhao X; Liu K; Wang L; Chen Q; Jiang H; Gao X; Lv X; Zhi X; Wu X; Li Y
    J Ethnopharmacol; 2023 Apr; 305():116128. PubMed ID: 36623754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research progress of astragaloside IV in treating acute kidney injury.
    Liu Y; Huang Y; Sun D; Ye N; Chen T; Yang M; Zhou L; Zou H
    Int Urol Nephrol; 2024 Aug; 56(8):2645-2650. PubMed ID: 38494585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances of traditional Chinese medicine against cardiovascular disease: overview and potential mechanisms.
    Dai J; Qiu L; Lu Y; Li M
    Front Endocrinol (Lausanne); 2024; 15():1366285. PubMed ID: 39403576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects.
    Zhang J; Wu C; Gao L; Du G; Qin X
    Adv Pharmacol; 2020; 87():89-112. PubMed ID: 32089240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragaloside IV relieves gestational diabetes mellitus in genetic mice through reducing hepatic gluconeogenesis.
    Zhang R; Xing B; Zhao J; Zhang X; Zhou L; Yang S; Wang Y; Yang F
    Can J Physiol Pharmacol; 2020 Jul; 98(7):466-472. PubMed ID: 32160476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases.
    Tan J; Yi J; Cao X; Wang F; Xie S; Dai A
    Drug Des Devel Ther; 2023; 17():1963-1978. PubMed ID: 37426627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV protects against polymicrobial sepsis through inhibiting inflammatory response and apoptosis of lymphocytes.
    Liu R; Jiang H; Tian Y; Zhao W; Wu X
    J Surg Res; 2016 Jan; 200(1):315-23. PubMed ID: 26375505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress.
    Lin J; Fang L; Li H; Li Z; Lyu L; Wang H; Xiao J
    Eur J Pharmacol; 2019 Sep; 859():172490. PubMed ID: 31229536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.